
Diversity Rises for Some but Not All in AxSpA Trials
TOPLINE: Axial spondyloarthritis (axSpA) clinical trials showed improved diversity, with increased representation of Asian and Hispanic/Latino participants. However, Black and Native Hawaiian/Pacific Islander groups remained underrepresented, and …